383 related articles for article (PubMed ID: 35056807)
1. In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties.
Perez E; Fernandez JR; Fitzgerald C; Rouzard K; Tamura M; Savile C
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056807
[TBL] [Abstract][Full Text] [Related]
2. The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination.
Robaina Cabrera CL; Keir-Rudman S; Horniman N; Clarkson N; Page C
Pulm Pharmacol Ther; 2021 Aug; 69():102047. PubMed ID: 34082108
[TBL] [Abstract][Full Text] [Related]
3. The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of
Henshaw FR; Dewsbury LS; Lim CK; Steiner GZ
Cannabis Cannabinoid Res; 2021 Jun; 6(3):177-195. PubMed ID: 33998900
[No Abstract] [Full Text] [Related]
4. Cannabidiol and Cannabigerol Exert Antimicrobial Activity without Compromising Skin Microbiota.
Luz-Veiga M; Amorim M; Pinto-Ribeiro I; Oliveira ALS; Silva S; Pimentel LL; Rodríguez-Alcalá LM; Madureira R; Pintado M; Azevedo-Silva J; Fernandes J
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768709
[TBL] [Abstract][Full Text] [Related]
5. Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se.
Hill AJ; Jones NA; Smith I; Hill CL; Williams CM; Stephens GJ; Whalley BJ
Neurosci Lett; 2014 Apr; 566():269-74. PubMed ID: 24642454
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways.
Viereckl MJ; Krutsinger K; Apawu A; Gu J; Cardona B; Barratt D; Han Y
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740979
[TBL] [Abstract][Full Text] [Related]
7. The Origin and Biomedical Relevance of Cannabigerol.
Jastrząb A; Jarocka-Karpowicz I; Skrzydlewska E
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887277
[TBL] [Abstract][Full Text] [Related]
8. Phytocannabinoids regulate inflammation in IL-1β-stimulated human gingival fibroblasts.
Abidi AH; Abhyankar V; Alghamdi SS; Tipton DA; Dabbous M
J Periodontal Res; 2022 Dec; 57(6):1127-1138. PubMed ID: 36070347
[TBL] [Abstract][Full Text] [Related]
9. Nonpsychotropic cannabinoids, abnormal cannabidiol and canabigerol-dimethyl heptyl, act at novel cannabinoid receptors to reduce intraocular pressure.
Szczesniak AM; Maor Y; Robertson H; Hung O; Kelly ME
J Ocul Pharmacol Ther; 2011 Oct; 27(5):427-35. PubMed ID: 21770780
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant and Neuroprotective Effects Induced by Cannabidiol and Cannabigerol in Rat CTX-TNA2 Astrocytes and Isolated Cortexes.
di Giacomo V; Chiavaroli A; Recinella L; Orlando G; Cataldi A; Rapino M; Di Valerio V; Ronci M; Leone S; Brunetti L; Menghini L; Zengin G; Ak G; Abdallah HH; Ferrante C
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443623
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid.
Gugliandolo A; Pollastro F; Grassi G; Bramanti P; Mazzon E
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986533
[TBL] [Abstract][Full Text] [Related]
12. Anti-Inflammatory Effects of Cannabigerol in Rheumatoid Arthritis Synovial Fibroblasts and Peripheral Blood Mononuclear Cell Cultures Are Partly Mediated by TRPA1.
Lowin T; Tigges-Perez MS; Constant E; Pongratz G
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614296
[TBL] [Abstract][Full Text] [Related]
13. The antinociceptive activity and mechanism of action of cannabigerol.
Wen Y; Wang Z; Zhang R; Zhu Y; Lin G; Li R; Zhang J
Biomed Pharmacother; 2023 Feb; 158():114163. PubMed ID: 36916438
[TBL] [Abstract][Full Text] [Related]
14. Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews.
Rock EM; Goodwin JM; Limebeer CL; Breuer A; Pertwee RG; Mechoulam R; Parker LA
Psychopharmacology (Berl); 2011 Jun; 215(3):505-12. PubMed ID: 21243485
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Cannabidiol on UV-Induced Changes in Intracellular Signaling of 3D-Cultured Skin Keratinocytes.
Gęgotek A; Atalay S; Rogowska-Wrzesińska A; Skrzydlewska E
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540902
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant function of phytocannabinoids: Molecular basis of their stability and cytoprotective properties under UV-irradiation.
Vacek J; Vostalova J; Papouskova B; Skarupova D; Kos M; Kabelac M; Storch J
Free Radic Biol Med; 2021 Feb; 164():258-270. PubMed ID: 33453360
[TBL] [Abstract][Full Text] [Related]
17. ¹H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specification.
Peschel W; Politi M
Talanta; 2015 Aug; 140():150-165. PubMed ID: 26048837
[TBL] [Abstract][Full Text] [Related]
18. Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol.
Mammana S; Cavalli E; Gugliandolo A; Silvestro S; Pollastro F; Bramanti P; Mazzon E
Medicina (Kaunas); 2019 Nov; 55(11):. PubMed ID: 31752240
[No Abstract] [Full Text] [Related]
19. Cannabidiol Effects on Phospholipid Metabolism in Keratinocytes from Patients with Psoriasis Vulgaris.
Jarocka-Karpowicz I; Biernacki M; Wroński A; Gęgotek A; Skrzydlewska E
Biomolecules; 2020 Feb; 10(3):. PubMed ID: 32121131
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease.
Borrelli F; Fasolino I; Romano B; Capasso R; Maiello F; Coppola D; Orlando P; Battista G; Pagano E; Di Marzo V; Izzo AA
Biochem Pharmacol; 2013 May; 85(9):1306-16. PubMed ID: 23415610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
